A newly detected flaw in a genetic signaling pathway that leads to a hyper-active inflammatory response could help explain why some people are more prone to develop severe osteoarthritis than others, according to University ...
Jul 13, 2022
0
10
The Laboratory Response Network (LRN) has facilitated rapid testing and detection of patients with monkeypox, according to research published in the July 8 early-release issue of the U.S. Centers for Disease Control and ...
Jul 12, 2022
0
8
Researchers from the University of Adelaide have found that a popular soup, bak kut teh, has the potential to cause liver failure by clashing with prescription medication.
Jul 12, 2022
0
22
A cross sectional study found that substantial discrepancies exist between individual estimated glomerular filtration rate (eGFR) and directly measured GFR (mGFR). Laboratory reports that provide eGFR calculations should ...
Jul 4, 2022
0
5
In a consensus statement published online June 15 in JAMA Dermatology, data is provided for optimizing laboratory monitoring of acne patients treated with isotretinoin.
Jun 29, 2022
0
3
There remains no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, state the authors of an updated Cochrane Review, which now contains 11 trials across 3,409 people. The authors note ...
Jun 24, 2022
1
39
Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable. Looking to better understand the underlying cause of this variation, a team led by researchers at Baylor ...
Jun 23, 2022
0
6
A team of scientists led by Professor Karsten Hiller from the Braunschweig Center for Systems Biology BRICS has discovered an endogenous, anti-inflammatory substance: mesaconic acid. This molecule could be a drug candidate ...
Jun 23, 2022
0
763
Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting. The study, published today in ...
Jun 21, 2022
0
285
A drug carrier able to reach the brain, bind to an aggressive type of tumor called glioblastoma multiforme, and release a chemotherapeutic agent has been tested for the first time by Brazilian researchers. According to an ...
Jun 14, 2022
0
34
